Tonix Pharmaceuticals Promotes Thomas Englese, MBA, to Chief Commercial Officer

Tonix Pharmaceuticals promoted Thomas Englese, MBA, to Chief Commercial Officer, effective immediately, the first time the company has filled that role. Englese has served as Executive Vice President, Commercial Operations, since September 2024. He continues to direct sales, marketing, market access, and commercial operations for TONMYA in fibromyalgia and the acute migraine products Zembrace SymTouch and Tosymra. CEO Seth Lederman called the promotion an important milestone, crediting Englese with building the commercial organization and launching TONMYA, which the company describes as a first-in-class, non-opioid analgesic and the first new fibromyalgia treatment in more than 15 years.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.